Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Evoked Potentials, Visual | 18 | 2001 | 417 | 1.750 |
Why?
|
Retinopathy of Prematurity | 18 | 2014 | 439 | 1.650 |
Why?
|
Retinal Detachment | 19 | 2018 | 428 | 1.370 |
Why?
|
Retinal Perforations | 10 | 2018 | 138 | 1.360 |
Why?
|
Retina | 20 | 2014 | 2655 | 1.290 |
Why?
|
Visual Acuity | 36 | 2014 | 2672 | 1.240 |
Why?
|
Macular Degeneration | 8 | 2014 | 1007 | 1.220 |
Why?
|
Electroretinography | 18 | 2015 | 524 | 1.210 |
Why?
|
Vitreous Body | 11 | 2012 | 399 | 0.790 |
Why?
|
Tissue Adhesives | 4 | 2015 | 173 | 0.680 |
Why?
|
Vision Disorders | 10 | 2001 | 1088 | 0.680 |
Why?
|
Vitrectomy | 14 | 2018 | 392 | 0.650 |
Why?
|
Eye Diseases | 7 | 2012 | 653 | 0.610 |
Why?
|
Vision Tests | 5 | 1998 | 161 | 0.600 |
Why?
|
Retinal Diseases | 7 | 2012 | 704 | 0.570 |
Why?
|
Tomography, Optical Coherence | 6 | 2018 | 2916 | 0.500 |
Why?
|
Pattern Recognition, Visual | 13 | 1997 | 824 | 0.500 |
Why?
|
Scotoma | 3 | 2008 | 130 | 0.430 |
Why?
|
Macula Lutea | 2 | 2008 | 177 | 0.390 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2011 | 22 | 0.380 |
Why?
|
Contrast Sensitivity | 5 | 2001 | 253 | 0.380 |
Why?
|
Retinoschisis | 1 | 2011 | 30 | 0.370 |
Why?
|
Retinal Neovascularization | 2 | 2004 | 288 | 0.350 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2012 | 251 | 0.350 |
Why?
|
Scleral Buckling | 6 | 2005 | 95 | 0.340 |
Why?
|
Biocompatible Materials | 4 | 2018 | 1683 | 0.330 |
Why?
|
Photoreceptor Cells, Vertebrate | 2 | 2008 | 203 | 0.320 |
Why?
|
Retinal Vein Occlusion | 3 | 1994 | 149 | 0.310 |
Why?
|
Resins, Synthetic | 1 | 2007 | 25 | 0.290 |
Why?
|
Optic Nerve Diseases | 4 | 2008 | 342 | 0.270 |
Why?
|
Visual Field Tests | 1 | 2008 | 411 | 0.260 |
Why?
|
Scattering, Radiation | 3 | 1999 | 490 | 0.260 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2004 | 354 | 0.240 |
Why?
|
Ophthalmoscopy | 5 | 2014 | 171 | 0.240 |
Why?
|
Fluorescein Angiography | 6 | 2014 | 1059 | 0.240 |
Why?
|
Membranes, Artificial | 1 | 2006 | 366 | 0.230 |
Why?
|
Rabbits | 9 | 2020 | 4770 | 0.230 |
Why?
|
Photic Stimulation | 7 | 1999 | 1987 | 0.220 |
Why?
|
Polyethylene Glycols | 3 | 2020 | 1182 | 0.220 |
Why?
|
Vitreoretinopathy, Proliferative | 3 | 2009 | 76 | 0.210 |
Why?
|
Hyaluronic Acid | 1 | 2006 | 483 | 0.200 |
Why?
|
Fundus Oculi | 10 | 2014 | 556 | 0.200 |
Why?
|
Platelet-Derived Growth Factor | 3 | 2009 | 618 | 0.190 |
Why?
|
Retinal Degeneration | 7 | 2003 | 413 | 0.190 |
Why?
|
Filtering Surgery | 1 | 2020 | 33 | 0.170 |
Why?
|
Contact Lenses | 1 | 2001 | 138 | 0.170 |
Why?
|
Infant, Newborn | 20 | 2009 | 26180 | 0.160 |
Why?
|
Electrodes | 1 | 2001 | 610 | 0.160 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2004 | 594 | 0.150 |
Why?
|
Electrooculography | 3 | 1993 | 113 | 0.150 |
Why?
|
Lymphokines | 3 | 2008 | 925 | 0.150 |
Why?
|
Enbucrilate | 1 | 1998 | 30 | 0.150 |
Why?
|
Tonometry, Ocular | 3 | 1995 | 235 | 0.150 |
Why?
|
Visual Fields | 5 | 1999 | 1062 | 0.140 |
Why?
|
Visual Pathways | 1 | 2001 | 551 | 0.140 |
Why?
|
Visually Impaired Persons | 1 | 1998 | 78 | 0.140 |
Why?
|
Laser Therapy | 2 | 2005 | 1092 | 0.130 |
Why?
|
Hydrogels | 2 | 2020 | 720 | 0.130 |
Why?
|
Intraocular Pressure | 5 | 2008 | 1294 | 0.130 |
Why?
|
Incontinentia Pigmenti | 2 | 2009 | 12 | 0.130 |
Why?
|
Imidazolidines | 1 | 1996 | 38 | 0.130 |
Why?
|
Male | 59 | 2014 | 360358 | 0.130 |
Why?
|
Humans | 88 | 2014 | 760617 | 0.120 |
Why?
|
Cornea | 1 | 2003 | 1332 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2013 | 563 | 0.120 |
Why?
|
Child, Preschool | 23 | 2011 | 42188 | 0.120 |
Why?
|
Child | 26 | 2014 | 80079 | 0.120 |
Why?
|
Galactose | 1 | 1996 | 294 | 0.120 |
Why?
|
Subretinal Fluid | 1 | 2014 | 24 | 0.120 |
Why?
|
Retinitis Pigmentosa | 1 | 1998 | 397 | 0.110 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2014 | 18 | 0.110 |
Why?
|
Infant | 21 | 2014 | 36152 | 0.110 |
Why?
|
Adolescent | 23 | 2014 | 88234 | 0.110 |
Why?
|
Light | 5 | 2001 | 1352 | 0.110 |
Why?
|
Lens, Crystalline | 1 | 1996 | 387 | 0.110 |
Why?
|
Vision, Low | 1 | 1995 | 163 | 0.110 |
Why?
|
Adult | 39 | 2014 | 220969 | 0.110 |
Why?
|
Female | 57 | 2014 | 392148 | 0.110 |
Why?
|
Aging | 2 | 2011 | 8699 | 0.110 |
Why?
|
Intraoperative Care | 2 | 2012 | 767 | 0.110 |
Why?
|
Aniseikonia | 1 | 1992 | 2 | 0.110 |
Why?
|
Vitreoretinal Surgery | 1 | 2012 | 28 | 0.100 |
Why?
|
Optic Nerve | 1 | 1996 | 572 | 0.100 |
Why?
|
Psychophysics | 4 | 1995 | 292 | 0.100 |
Why?
|
Gyrate Atrophy | 1 | 1991 | 16 | 0.100 |
Why?
|
Depth Perception | 1 | 1992 | 94 | 0.100 |
Why?
|
Diabetic Retinopathy | 1 | 2001 | 1273 | 0.100 |
Why?
|
Sensory Thresholds | 4 | 1994 | 377 | 0.100 |
Why?
|
Wound Healing | 1 | 2003 | 2802 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2007 | 2495 | 0.100 |
Why?
|
Chorioretinitis | 1 | 1991 | 43 | 0.090 |
Why?
|
Retinal Pigment Epithelium | 1 | 2014 | 303 | 0.090 |
Why?
|
Middle Aged | 30 | 2014 | 220584 | 0.090 |
Why?
|
Lenses, Intraocular | 1 | 1992 | 139 | 0.090 |
Why?
|
Paraneoplastic Syndromes | 1 | 1992 | 155 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2009 | 368 | 0.090 |
Why?
|
Visual Perception | 2 | 1995 | 1388 | 0.080 |
Why?
|
Anterior Eye Segment | 2 | 1990 | 143 | 0.080 |
Why?
|
Ophthalmoscopes | 1 | 2008 | 20 | 0.080 |
Why?
|
Fibrinolysin | 1 | 2008 | 131 | 0.070 |
Why?
|
Retinal Artery | 1 | 2008 | 109 | 0.070 |
Why?
|
Eye Foreign Bodies | 2 | 2001 | 52 | 0.070 |
Why?
|
Endophthalmitis | 1 | 2010 | 260 | 0.070 |
Why?
|
Aged | 22 | 2014 | 169042 | 0.070 |
Why?
|
Gestational Age | 3 | 2005 | 3577 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1349 | 0.070 |
Why?
|
Uveitis | 1 | 1991 | 396 | 0.070 |
Why?
|
Joint Diseases | 2 | 1982 | 459 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2001 | 3415 | 0.070 |
Why?
|
Trypan Blue | 1 | 2006 | 22 | 0.070 |
Why?
|
Vitreous Hemorrhage | 2 | 2001 | 48 | 0.060 |
Why?
|
Eye | 3 | 2009 | 712 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 768 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3769 | 0.060 |
Why?
|
Genes, Dominant | 6 | 1988 | 851 | 0.060 |
Why?
|
Microsurgery | 1 | 2010 | 793 | 0.060 |
Why?
|
Tissue Adhesions | 1 | 2006 | 218 | 0.060 |
Why?
|
Nerve Fibers | 1 | 2008 | 707 | 0.060 |
Why?
|
Eye Neoplasms | 2 | 1996 | 307 | 0.060 |
Why?
|
Cryotherapy | 1 | 2005 | 159 | 0.060 |
Why?
|
Permeability | 1 | 2006 | 721 | 0.060 |
Why?
|
Glucose | 1 | 1996 | 4345 | 0.060 |
Why?
|
Fourier Analysis | 2 | 1997 | 440 | 0.060 |
Why?
|
Sphygmomanometers | 1 | 2003 | 19 | 0.060 |
Why?
|
Materials Testing | 1 | 2007 | 862 | 0.050 |
Why?
|
Cataract | 2 | 2003 | 831 | 0.050 |
Why?
|
Blindness | 2 | 1996 | 584 | 0.050 |
Why?
|
Membrane Proteins | 3 | 1995 | 7847 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2005 | 80566 | 0.050 |
Why?
|
Injections | 1 | 2006 | 832 | 0.050 |
Why?
|
Cranial Sutures | 1 | 2003 | 92 | 0.050 |
Why?
|
Eye Diseases, Hereditary | 1 | 2003 | 122 | 0.050 |
Why?
|
Disease Models, Animal | 6 | 2018 | 18221 | 0.050 |
Why?
|
Aged, 80 and over | 11 | 2003 | 58894 | 0.050 |
Why?
|
Retinal Ganglion Cells | 1 | 2008 | 810 | 0.050 |
Why?
|
Follow-Up Studies | 10 | 2003 | 39063 | 0.050 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2003 | 103 | 0.050 |
Why?
|
Abnormalities, Multiple | 2 | 1986 | 1422 | 0.050 |
Why?
|
Glaucoma, Open-Angle | 1 | 2008 | 738 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 1994 | 3077 | 0.050 |
Why?
|
Animals | 13 | 2020 | 168201 | 0.050 |
Why?
|
Conjunctiva | 3 | 2010 | 479 | 0.050 |
Why?
|
Silicone Elastomers | 1 | 2001 | 78 | 0.050 |
Why?
|
Laser Coagulation | 1 | 2003 | 330 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2015 | 5239 | 0.040 |
Why?
|
Cattle | 1 | 2006 | 3841 | 0.040 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2001 | 184 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2009 | 3492 | 0.040 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2001 | 410 | 0.040 |
Why?
|
Osteoporosis | 2 | 2001 | 1604 | 0.040 |
Why?
|
Pedigree | 7 | 2003 | 4539 | 0.040 |
Why?
|
Mitomycin | 1 | 2020 | 263 | 0.040 |
Why?
|
Retinal Vessels | 4 | 2009 | 852 | 0.040 |
Why?
|
Eye Abnormalities | 1 | 2001 | 242 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3527 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2001 | 488 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 2001 | 219 | 0.040 |
Why?
|
Connective Tissue Diseases | 3 | 1988 | 285 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2000 | 271 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 3 | 1995 | 1798 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 2073 | 0.040 |
Why?
|
Blotting, Western | 4 | 2009 | 5034 | 0.040 |
Why?
|
Cryosurgery | 1 | 2003 | 468 | 0.040 |
Why?
|
Syndrome | 8 | 2001 | 3268 | 0.040 |
Why?
|
Psychophysiology | 1 | 1998 | 135 | 0.040 |
Why?
|
Pierre Robin Syndrome | 1 | 1979 | 117 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 673 | 0.040 |
Why?
|
Area Under Curve | 1 | 2001 | 1635 | 0.040 |
Why?
|
Prognosis | 7 | 1995 | 29600 | 0.030 |
Why?
|
Medical Illustration | 1 | 1998 | 135 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13495 | 0.030 |
Why?
|
Cell Culture Techniques | 3 | 2009 | 1662 | 0.030 |
Why?
|
Osteoblasts | 1 | 2001 | 1141 | 0.030 |
Why?
|
Aldehyde Reductase | 1 | 1996 | 70 | 0.030 |
Why?
|
Administration, Topical | 1 | 1998 | 703 | 0.030 |
Why?
|
Pentose Phosphate Pathway | 1 | 1996 | 126 | 0.030 |
Why?
|
Ischemia | 2 | 1994 | 1884 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2001 | 1015 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2015 | 64568 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 1996 | 458 | 0.030 |
Why?
|
Lipofuscin | 1 | 2014 | 40 | 0.030 |
Why?
|
Callithrix | 1 | 1994 | 95 | 0.030 |
Why?
|
Immunoblotting | 2 | 2008 | 1646 | 0.030 |
Why?
|
Nitrites | 1 | 2014 | 159 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 1963 | 0.030 |
Why?
|
Gonioscopy | 2 | 1993 | 155 | 0.030 |
Why?
|
Precipitin Tests | 1 | 1994 | 813 | 0.030 |
Why?
|
Ultrasonography | 3 | 2004 | 5964 | 0.030 |
Why?
|
Retinal Hemorrhage | 1 | 1994 | 95 | 0.030 |
Why?
|
Intravitreal Injections | 1 | 2015 | 385 | 0.030 |
Why?
|
Antigens, CD | 2 | 1995 | 3998 | 0.030 |
Why?
|
Lymphocyte Activation | 5 | 1995 | 5463 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1996 | 317 | 0.030 |
Why?
|
Reoperation | 1 | 2003 | 4300 | 0.030 |
Why?
|
Eye Injuries, Penetrating | 1 | 1995 | 124 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11069 | 0.030 |
Why?
|
Vision Disparity | 1 | 1992 | 28 | 0.030 |
Why?
|
Ornithine | 1 | 1991 | 79 | 0.020 |
Why?
|
Dark Adaptation | 1 | 1993 | 222 | 0.020 |
Why?
|
Glaucoma | 2 | 1993 | 1185 | 0.020 |
Why?
|
Flicker Fusion | 1 | 1991 | 14 | 0.020 |
Why?
|
Amblyopia | 1 | 1994 | 150 | 0.020 |
Why?
|
Iris | 2 | 1990 | 232 | 0.020 |
Why?
|
Antibodies, Monoclonal | 4 | 2009 | 9172 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 1994 | 4366 | 0.020 |
Why?
|
Capillaries | 1 | 2014 | 756 | 0.020 |
Why?
|
Cell Polarity | 1 | 2014 | 635 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 59179 | 0.020 |
Why?
|
Collagen | 3 | 1988 | 2634 | 0.020 |
Why?
|
Vision, Binocular | 1 | 1992 | 226 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1994 | 454 | 0.020 |
Why?
|
Oscillometry | 1 | 1991 | 150 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1992 | 897 | 0.020 |
Why?
|
Imidazoles | 1 | 1996 | 1175 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2008 | 4533 | 0.020 |
Why?
|
Electrophysiology | 1 | 1992 | 1262 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1993 | 1605 | 0.020 |
Why?
|
Motion Perception | 1 | 1993 | 374 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2010 | 15612 | 0.020 |
Why?
|
Myopia | 3 | 2001 | 252 | 0.020 |
Why?
|
Endoscopy | 1 | 1999 | 1851 | 0.020 |
Why?
|
Epiretinal Membrane | 1 | 2009 | 73 | 0.020 |
Why?
|
Polymers | 1 | 1996 | 1614 | 0.020 |
Why?
|
Time Factors | 3 | 2003 | 39913 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1998 | 2417 | 0.020 |
Why?
|
Bone Density | 1 | 2001 | 3548 | 0.020 |
Why?
|
Mice, Inbred BALB C | 2 | 1994 | 6188 | 0.020 |
Why?
|
alpha-2-Antiplasmin | 1 | 2008 | 13 | 0.020 |
Why?
|
Cataract Extraction | 1 | 1992 | 467 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6338 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2008 | 239 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5491 | 0.020 |
Why?
|
Fibroblasts | 2 | 2009 | 4137 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 178 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6224 | 0.020 |
Why?
|
Phosphorylation | 2 | 2009 | 8311 | 0.020 |
Why?
|
Lasers | 1 | 1991 | 952 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2009 | 3730 | 0.020 |
Why?
|
Mice | 6 | 2014 | 81368 | 0.020 |
Why?
|
Pigment Epithelium of Eye | 1 | 2007 | 209 | 0.020 |
Why?
|
Genes, Recessive | 2 | 2001 | 623 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2007 | 183 | 0.020 |
Why?
|
Bone Diseases, Developmental | 1 | 1986 | 131 | 0.020 |
Why?
|
Dwarfism | 1 | 1986 | 138 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 1993 | 14591 | 0.020 |
Why?
|
Collagen Type I | 1 | 2009 | 616 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1884 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 876 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 2135 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5907 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1996 | 3705 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3800 | 0.020 |
Why?
|
Decision Making | 1 | 1999 | 3918 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2001 | 1989 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2008 | 1496 | 0.010 |
Why?
|
Tyrosine | 1 | 2009 | 1440 | 0.010 |
Why?
|
Antifibrinolytic Agents | 1 | 2008 | 287 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1370 | 0.010 |
Why?
|
Cells, Cultured | 3 | 2014 | 18937 | 0.010 |
Why?
|
Collagen Type XI | 1 | 2003 | 21 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1986 | 258 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2001 | 22148 | 0.010 |
Why?
|
Cell Line | 2 | 1994 | 15576 | 0.010 |
Why?
|
Action Potentials | 1 | 1991 | 1825 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1999 | 8998 | 0.010 |
Why?
|
Blood Proteins | 1 | 2008 | 1172 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2007 | 1697 | 0.010 |
Why?
|
Animals, Outbred Strains | 1 | 2001 | 20 | 0.010 |
Why?
|
Jaw Abnormalities | 1 | 1982 | 27 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12966 | 0.010 |
Why?
|
Wnt2 Protein | 1 | 2001 | 28 | 0.010 |
Why?
|
Cytokines | 2 | 2014 | 7373 | 0.010 |
Why?
|
Tissue Plasminogen Activator | 1 | 2008 | 1163 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1650 | 0.010 |
Why?
|
Genetic Linkage | 3 | 1996 | 2340 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 329 | 0.010 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2001 | 118 | 0.010 |
Why?
|
Clone Cells | 2 | 1995 | 1657 | 0.010 |
Why?
|
Glioma | 1 | 1996 | 3453 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1670 | 0.010 |
Why?
|
Calcium | 1 | 1994 | 5717 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1994 | 4745 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1999 | 15828 | 0.010 |
Why?
|
Prospective Studies | 4 | 2008 | 54360 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 522 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3268 | 0.010 |
Why?
|
Preoperative Care | 1 | 2009 | 2241 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 2000 | 212 | 0.010 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2001 | 343 | 0.010 |
Why?
|
COS Cells | 1 | 2001 | 1130 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2001 | 794 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5758 | 0.010 |
Why?
|
Receptors, Growth Factor | 1 | 2000 | 326 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2048 | 0.010 |
Why?
|
Maxilla | 1 | 1982 | 494 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1994 | 14648 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2009 | 2644 | 0.010 |
Why?
|
Mesoderm | 1 | 2001 | 674 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10432 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 748 | 0.010 |
Why?
|
Body Fluids | 1 | 2000 | 320 | 0.010 |
Why?
|
Mutation | 2 | 2001 | 30016 | 0.010 |
Why?
|
Endoscopes | 1 | 1999 | 168 | 0.010 |
Why?
|
Alleles | 2 | 2001 | 6861 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2001 | 718 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1995 | 20074 | 0.010 |
Why?
|
Species Specificity | 1 | 2001 | 2411 | 0.010 |
Why?
|
Skull | 1 | 2001 | 818 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2000 | 664 | 0.010 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2001 | 841 | 0.010 |
Why?
|
Hearing Loss | 1 | 2003 | 781 | 0.010 |
Why?
|
Stromal Cells | 1 | 2001 | 1329 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1993 | 10175 | 0.010 |
Why?
|
Cleft Palate | 1 | 1982 | 589 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2000 | 571 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2000 | 2261 | 0.010 |
Why?
|
Eye Enucleation | 1 | 1996 | 128 | 0.010 |
Why?
|
Device Removal | 1 | 2001 | 629 | 0.010 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1982 | 781 | 0.010 |
Why?
|
Heterozygote | 1 | 2001 | 2780 | 0.010 |
Why?
|
Consanguinity | 1 | 1996 | 456 | 0.010 |
Why?
|
Genes | 2 | 1988 | 1823 | 0.010 |
Why?
|
Transfection | 1 | 2001 | 5766 | 0.010 |
Why?
|
Risk Factors | 1 | 2001 | 74115 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 1545 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2001 | 2446 | 0.010 |
Why?
|
Face | 1 | 1979 | 1026 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2000 | 1626 | 0.010 |
Why?
|
Phenotype | 4 | 1987 | 16571 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2001 | 6520 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2007 | 14389 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2001 | 2895 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2001 | 4242 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2001 | 4739 | 0.010 |
Why?
|
Genetic Markers | 1 | 1996 | 2601 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4512 | 0.010 |
Why?
|
Risk Assessment | 1 | 2010 | 23972 | 0.000 |
Why?
|
Random Allocation | 1 | 1993 | 2392 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1992 | 1463 | 0.000 |
Why?
|
Recurrence | 1 | 2001 | 8426 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1996 | 4611 | 0.000 |
Why?
|
Cell Communication | 1 | 1995 | 1654 | 0.000 |
Why?
|
Down-Regulation | 1 | 1995 | 2915 | 0.000 |
Why?
|
Restriction Mapping | 1 | 1988 | 851 | 0.000 |
Why?
|
Calcinosis | 1 | 1996 | 1469 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 26049 | 0.000 |
Why?
|
Cell Adhesion | 1 | 1993 | 3088 | 0.000 |
Why?
|
Proteins | 1 | 2001 | 6030 | 0.000 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1987 | 767 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1992 | 1887 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1994 | 5863 | 0.000 |
Why?
|
Electrophoresis | 1 | 1983 | 226 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 22115 | 0.000 |
Why?
|
DNA | 1 | 1996 | 7196 | 0.000 |
Why?
|
Molecular Weight | 1 | 1983 | 2185 | 0.000 |
Why?
|
Fibrin | 1 | 1983 | 507 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1994 | 12758 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1983 | 2467 | 0.000 |
Why?
|
Signal Transduction | 1 | 2001 | 23416 | 0.000 |
Why?
|
Amino Acids | 1 | 1983 | 1717 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1994 | 11874 | 0.000 |
Why?
|
Incidence | 1 | 1993 | 21337 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1996 | 20556 | 0.000 |
Why?
|